Assisted Reproductive Technology - Company Evaluation Report, 2025
Description
The Assisted Reproductive Technology Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Assisted Reproductive Technology. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and industry trends. MarketsandMarkets 360 Quadrants evaluated over 140 companies, of which the Top 15 Assisted Reproductive Technology Companies were categorized and recognized as the quadrant leaders.
The 360 Quadrant maps the Assisted Reproductive Technology companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Assisted Reproductive Technology quadrant. The top criteria for product footprint evaluation included Type [In Vitro Fertilization (IVF) (IVF with Intracytoplasmic Sperm Injection [ICSI], IVF without Intracytoplasmic Sperm Injection [ICSI]), Artificial Insemination], Product Type [Instruments (Embryo Incubators, Sperm Analyzer Systems, Micromanipulators, Other Instruments), Media (Cryopreservation Media, Ovum Processing Media, Embryo Culture Media, Semen Processing Media), Supplements, Consumables (Culture Dishes & Plates, Storage Containers, Cryovials & Tubes, Other Consumables)], End User [Fertility Clinics, Hospitals & Surgery Clinics, Cryobanks, Research Institutes], Patient Type [Male Patients, Female Patients].
Key Players:
Major vendors in the Assisted Reproductive Technology market are CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), Cook Medical Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea BIOMEDX (Australia), Thermo Fisher Scientific Inc. (US), LENUS Pharma GesmbH (Austria), Zita West (UK), Kitazato Corporation (Japan), Exeltis USA, Inc. (US), Vitabiotics Ltd (UK), FertiPro NV (Belgium), and AdvaCare Pharma (US). The key strategies major vendors implement in the Assisted Reproductive Technology market are partnerships, collaborations, product launches, and product enhancements.
CooperSurgical Inc.
CooperSurgical Inc. is a leading global company in women's health and a dominant force in the fertility market. Through its comprehensive portfolio, it provides a vast range of medical devices for obstetrics and gynecology alongside a complete suite of solutions for the entire IVF process. Strategically, CooperSurgical has established itself as a one-stop shop for fertility clinics, offering everything from advanced culture media and lab equipment to industry-leading preimplantation genetic testing services. This integrated approach solidifies customer loyalty and reinforces its powerful position in the rapidly evolving assisted reproductive technology (ART) landscape.
Vitrolife
Sweden's Vitrolife is a global leader in the fertility field, renowned for its high-quality products and deep scientific focus. The company provides a comprehensive portfolio for the ART laboratory, including premium IVF culture media, advanced cryopreservation solutions, and its pioneering EmbryoScope time-lapse incubators. Following its transformative merger with genetics leader Igenomix, Vitrolife’s strategy is to offer a synergistic suite of consumables, technology, and reproductive genetic testing. This powerful combination of best-in-class products and advanced genetic services cements its position as a key partner for IVF clinics aiming for superior clinical outcomes.
FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific is a global leader in the development and manufacture of advanced cell culture media. As a key part of FUJIFILM’s life sciences division, it serves three core markets: Assisted Reproductive Technology (ART), bioproduction, and cell and gene therapy. While a major provider of IVF media, its strategic focus is on the high-growth bioproduction space, where it offers optimized media to improve the manufacturing of biologics and vaccines. By leveraging FUJIFILM's renowned quality systems and manufacturing expertise, the company maintains its strong position as a critical supplier for both fertility clinics and biopharmaceutical companies.
The 360 Quadrant maps the Assisted Reproductive Technology companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Assisted Reproductive Technology quadrant. The top criteria for product footprint evaluation included Type [In Vitro Fertilization (IVF) (IVF with Intracytoplasmic Sperm Injection [ICSI], IVF without Intracytoplasmic Sperm Injection [ICSI]), Artificial Insemination], Product Type [Instruments (Embryo Incubators, Sperm Analyzer Systems, Micromanipulators, Other Instruments), Media (Cryopreservation Media, Ovum Processing Media, Embryo Culture Media, Semen Processing Media), Supplements, Consumables (Culture Dishes & Plates, Storage Containers, Cryovials & Tubes, Other Consumables)], End User [Fertility Clinics, Hospitals & Surgery Clinics, Cryobanks, Research Institutes], Patient Type [Male Patients, Female Patients].
Key Players:
Major vendors in the Assisted Reproductive Technology market are CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), Cook Medical Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea BIOMEDX (Australia), Thermo Fisher Scientific Inc. (US), LENUS Pharma GesmbH (Austria), Zita West (UK), Kitazato Corporation (Japan), Exeltis USA, Inc. (US), Vitabiotics Ltd (UK), FertiPro NV (Belgium), and AdvaCare Pharma (US). The key strategies major vendors implement in the Assisted Reproductive Technology market are partnerships, collaborations, product launches, and product enhancements.
CooperSurgical Inc.
CooperSurgical Inc. is a leading global company in women's health and a dominant force in the fertility market. Through its comprehensive portfolio, it provides a vast range of medical devices for obstetrics and gynecology alongside a complete suite of solutions for the entire IVF process. Strategically, CooperSurgical has established itself as a one-stop shop for fertility clinics, offering everything from advanced culture media and lab equipment to industry-leading preimplantation genetic testing services. This integrated approach solidifies customer loyalty and reinforces its powerful position in the rapidly evolving assisted reproductive technology (ART) landscape.
Vitrolife
Sweden's Vitrolife is a global leader in the fertility field, renowned for its high-quality products and deep scientific focus. The company provides a comprehensive portfolio for the ART laboratory, including premium IVF culture media, advanced cryopreservation solutions, and its pioneering EmbryoScope time-lapse incubators. Following its transformative merger with genetics leader Igenomix, Vitrolife’s strategy is to offer a synergistic suite of consumables, technology, and reproductive genetic testing. This powerful combination of best-in-class products and advanced genetic services cements its position as a key partner for IVF clinics aiming for superior clinical outcomes.
FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific is a global leader in the development and manufacture of advanced cell culture media. As a key part of FUJIFILM’s life sciences division, it serves three core markets: Assisted Reproductive Technology (ART), bioproduction, and cell and gene therapy. While a major provider of IVF media, its strategic focus is on the high-growth bioproduction space, where it offers optimized media to improve the manufacturing of biologics and vaccines. By leveraging FUJIFILM's renowned quality systems and manufacturing expertise, the company maintains its strong position as a critical supplier for both fertility clinics and biopharmaceutical companies.
Table of Contents
113 Pages
- 1 Introduction
- 1.1 Market Definition
- 1.2 Stakeholders
- 2 Executive Summary
- 3 Market Overview
- 3.1 Introduction
- 3.2 Market Dynamics
- 3.2.1 Drivers
- 3.2.1.1 Increasing Median Age Of Pregnancy
- 3.2.1.2 Rising Infertility Rate
- 3.2.1.3 Booming Fertility Industry
- 3.2.1.4 Evolving Technological Landscape
- 3.2.1.5 Favorable Government Initiatives
- 3.2.2 Restraints
- 3.2.2.1 High Cost Of Ivf Procedures
- 3.2.2.2 Social And Ethical Concerns In Developing Countries
- 3.2.2.3 Elevated Risk Of Complications
- 3.2.3 Opportunities
- 3.2.3.1 Growth Opportunities In Emerging Economies
- 3.2.3.2 Availability Of Diverse Range Of Fertility Treatment Options
- 3.2.4 Challenges
- 3.2.4.1 Reduced Efficacy Of Infertility Treatments For Patients Of
- Advanced Age
- 3.3 Trends/Disruptions Impacting Customer Business
- 3.4 Value Chain Analysis
- 3.4.1 Research & Product Development
- 3.4.2 Raw Material Procurement And Manufacturing
- 3.4.3 Distribution, Marketing & Sales, And Post-sales Services
- 3.5 Supply Chain Analysis
- 3.5.1 Prominent Companies
- 3.5.2 Small And Medium-sized Enterprises
- 3.5.3 End Users
- 3.6 Ecosystem Analysis
- 3.7 Technology Analysis
- 3.7.1 Key Technologies
- 3.7.1.1 Time-lapse Technology
- 3.7.2 Complementary Technologies
- 3.7.2.1 Preimplantation Genetic Testing
- 3.7.3 Adjacent Technologies
- 3.7.3.1 Sperm Cryopreservation
- 3.7.3.2 Oocyte Cryopreservation
- 3.8 Patent Analysis
- 3.9 Key Conferences And Events, 2025–2026
- 3.10 Porter’s Five Forces Analysis
- 3.10.1 Threat Of New Entrants
- 3.10.2 Threat Of Substitutes
- 3.10.3 Bargaining Power Of Buyers
- 3.10.4 Bargaining Power Of Suppliers
- 3.10.5 Intensity Of Competitive Rivalry
- 3.11 Reimbursement Scenario
- 3.12 Impact Of Ai/Gen Ai On Assisted Reproductive Technology Market
- 3.12.1 Introduction
- 3.12.2 Market Potential Of Ai In Assisted Reproductive Technology
- 3.12.3 Use Cases
- 3.12.4 Key Companies Implementing Ai
- 3.12.5 Future Of Generative Ai In Assisted Reproductive
- Technology Market
- 4 Competitive Landscape
- 4.1 Overview
- 4.2 Key Player Strategies/Right To Win
- 4.2.1 Overview Of Strategies Adopted By Players In Assisted Reproductive Technology Market
- 4.3 Revenue Analysis, 2020–2024
- 4.4 Market Share Analysis, 2024
- 4.5 Company Valuation And Financial Metrics
- 4.5.1 Company Valuation
- 4.5.2 Financial Metrics
- 4.6 Brand/Product Comparison
- 4.7 Company Evaluation Matrix: Key Players, 2024
- 4.7.1 Stars
- 4.7.2 Emerging Leaders
- 4.7.3 Pervasive Players
- 4.7.4 Participants
- 4.7.5 Company Footprint: Key Players, 2024
- 4.7.5.1 Company Footprint
- 4.7.5.2 Region Footprint
- 4.7.5.3 Type Footprint
- 4.7.5.4 Product Type Footprint
- 4.7.5.5 Patient Type Footprint
- 4.7.5.6 End-user Footprint
- 4.8 Company Evaluation Matrix: Startups/Smes, 2024
- 4.8.1 Progressive Companies
- 4.8.2 Responsive Companies
- 4.8.3 Dynamic Companies
- 4.8.4 Starting Blocks
- 4.8.5 Competitive Benchmarking: Startups/Smes, 2024
- 4.8.5.1 Detailed List Of Key Startups/Smes
- 4.8.5.2 Competitive Benchmarking Of Key Startups/Smes
- 4.9 Competitive Scenario
- 4.9.1 Product Launches
- 4.9.2 Deals
- 4.9.3 Other Developments
- 5 Company Profiles
- 5.1 Key Players
- 5.1.1 Coopersurgical Inc.
- 5.1.1.1 Business Overview
- 5.1.1.2 Products Offered
- 5.1.1.3 Recent Developments
- 5.1.1.3.1 Deals
- 5.1.1.4 Mnm View
- 5.1.1.4.1 Key Strengths
- 5.1.1.4.2 Strategic Choices
- 5.1.1.4.3 Weaknesses And Competitive Threats
- 5.1.2 Fujifilm Irvine Scientific
- 5.1.2.1 Business Overview
- 5.1.2.2 Products Offered
- 5.1.2.3 Recent Developments
- 5.1.2.3.1 Deals
- 5.1.2.3.2 Other Developments
- 5.1.2.4 Mnm View
- 5.1.2.4.1 Key Strengths
- 5.1.2.4.2 Strategic Choices
- 5.1.2.4.3 Weaknesses
- 5.1.3 Vitrolife
- 5.1.3.1 Business Overview
- 5.1.3.2 Products Offered
- 5.1.3.3 Recent Developments
- 5.1.3.3.1 Deals
- 5.1.3.4 Mnm View
- 5.1.3.4.1 Key Strengths
- 5.1.3.4.2 Strategic Choices
- 5.1.3.4.3 Weaknesses And Competitive Threats
- 5.1.4 Thermo Fisher Scientific Inc.
- 5.1.4.1 Business Overview
- 5.1.4.2 Products Offered
- 5.1.4.3 Mnm View
- 5.1.4.3.1 Key Strengths
- 5.1.4.3.2 Strategic Choices
- 5.1.4.3.3 Weaknesses And Competitive Threats
- 5.1.5 Cook Medical Inc.
- 5.1.5.1 Business Overview
- 5.1.5.2 Products Offered
- 5.1.5.3 Recent Developments
- 5.1.5.3.1 Product Launches
- 5.1.5.3.2 Deals
- 5.1.5.4 Mnm View
- 5.1.5.4.1 Key Strengths
- 5.1.5.4.2 Strategic Choices
- 5.1.5.4.3 Weaknesses And Competitive Threats
- 5.1.6 Hamilton Thorne
- 5.1.6.1 Business Overview
- 5.1.6.2 Products Offered
- 5.1.6.3 Recent Developments
- 5.1.6.3.1 Deals
- 5.1.6.4 Mnm View
- 5.1.6.4.1 Key Strengths
- 5.1.6.4.2 Strategic Choices
- 5.1.6.4.3 Weaknesses And Competitive Threats
- 5.1.7 Kitazato Corporation
- 5.1.7.1 Business Overview
- 5.1.7.2 Products Offered
- 5.1.7.3 Recent Developments
- 5.1.7.3.1 Deals
- 5.1.8 Esco Micro Pte. Ltd.
- 5.1.8.1 Business Overview
- 5.1.8.2 Products Offered
- 5.1.8.3 Recent Developments
- 5.1.8.3.1 Deals
- 5.1.9 Fertipro Nv
- 5.1.9.1 Business Overview
- 5.1.9.2 Products Offered
- 5.1.10 Genea Biomedx
- 5.1.10.1 Business Overview
- 5.1.10.2 Products Offered
- 5.1.10.3 Recent Developments
- 5.1.10.3.1 Deals
- 5.1.11 Lenus Pharma Gesmbh
- 5.1.11.1 Business Overview
- 5.1.11.2 Products Offered
- 5.1.11.3 Recent Developments
- 5.1.11.3.1 Product Launches
- 5.1.12 Zita West
- 5.1.12.1 Business Overview
- 5.1.12.2 Products Offered
- 5.1.13 Exeltis Usa, Inc.
- 5.1.13.1 Business Overview
- 5.1.13.2 Products Offered
- 5.1.14 Vitabiotics Ltd.
- 5.1.14.1 Business Overview
- 5.1.14.2 Products Offered
- 5.1.15 Advacare Pharma
- 5.1.15.1 Business Overview
- 5.1.15.2 Products Offered
- 5.2 Other Companies
- 5.2.1 Fairhaven Health
- 5.2.2 Shanghai Unicorn Medical Technology Co., Ltd.
- 5.2.3 Gynemed Gmbh & Co. Kg
- 5.2.4 Invitrocare Inc.
- 5.2.5 Ivftech
- 5.2.6 Labivf Asia Pte Ltd.
- 5.2.7 Coast Science
- 5.2.8 Bioimager Inc.
- 5.2.9 Shivani Scientific
- 5.2.10 Minitüb Gmbh
- 6 Appendix
- 6.1 Research Methodology
- 6.1.1 Research Data
- 6.1.2 Research Design
- 6.1.2.1 Secondary Research
- 6.1.2.2 Primary Research
- 6.1.3 Research Assumptions
- 6.1.4 Research Limitations
- 6.1.5 Risk Assessment
- 6.2 Company Evaluation Matrix: Methodology
- 6.3 Author Details
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
